Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Supply readiness follows months of manufacturing to ensure timely and ample supply
GenWorks has scaled up its e-commerce platform in terms of building traffic
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Augnito’s AI comprehends all English accents with 99% accuracy
This product will be manufactured at Lupin's Pithampur facility in India
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Subscribe To Our Newsletter & Stay Updated
